Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers compared TAK-063 20 mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including SpringdaleA Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
This study has finished and is no longer accepting participants.
In TorontoA Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
This study ended early.
Multiple locations, including MaitlandResearchers compared 225 mg BNC210, 675 mg BNC210 and placebo, tracking side effects to assess safety in people with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including Beverly HillsResearchers compared ABT-126 and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ChinoA Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of KH607 in the Treatment of Adult Participants With Moderate or Severe Major Depressive Disorder
This study has finished and is no longer accepting participants.
In BeijingA Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of KH607 in the Treatment of Adult Female Participants With Postpartum Depressive Disorder
This study has finished and is no longer accepting participants.
In BeijingThis study evaluated the safety and effectiveness of CTP-692 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.